INmune Bio Inc. Common stock (INMB) Dividend History

INmune Bio Inc. (INMB) is a clinical-stage biotechnology company focused on developing novel immunotherapies to treat neurodegenerative diseases, cancer, and infectious diseases. The company's approach involves targeting specific immune pathways to modulate the immune response and improve patient outcomes. INmune Bio aims to advance therapies that leverage the body's immune system to fight various diseases more effectively.

225 Ne Mizner Blvd, Suite 640, Boca Raton, FL, 33432
Phone: (858) 964-3720
Website: https://www.inmunebio.com

Dividend History

INmune Bio Inc. Common stock currently does not pay dividends

Company News

  • INmune Bio will host a conference call on June 30, 2025, to present top line data from their Phase 2 MINDFuL trial investigating XPro™ treatment for early Alzheimer's Disease, focusing on patients with mild cognitive impairment and neuroinflammation markers.

    GlobeNewswire Inc.
  • Inmune Bio, a biopharmaceutical company, held its annual stockholders meeting, resulting in the re-election of its board of directors and the ratification of its independent auditor for the upcoming fiscal year.

    Investing.com
  • Upgrades For Banco Latinoamericano de Comercio Exterior SA (NYSE:BLX), Credit Suisse upgraded the previous rating of Neutral to Outperform. Banco Latinoamericano earned $1.02 in the first quarter, compared to $0.31 in the year-ago quarter. The stock has a 52-week-high of $20.48 and a 52-week-low of $12.59. At the end of the last trading period, Banco Latinoamericano closed at $19.49. B of A Securities upgraded the previous rating for Genuine Parts Co (NYSE:GPC) from Neutral to Buy. In the first quarter, Genuine Parts showed an EPS of $2.14, compared to $1.86 from the year-ago quarter. At the moment, the stock has a 52-week-high of $187.61 and a 52-week-low of $127.01. Genuine Parts closed at $147.98 at the end of the last trading period. For Lear Corp (NYSE:LEA), Exane BNP Paribas upgraded the previous rating of Neutral to Outperform. Lear earned $2.78 in the first quarter, compared to $1.80 in the year-ago quarter. The stock has a 52-week-high of $158.38 and a 52-week-low of $115.09. At the end of the last trading period, Lear closed at $122.66. According to Raymond James, the prior rating for The Carlyle Group Inc (NASDAQ:CG) was changed from Market Perform to Outperform. For the first quarter, Carlyle Group had an EPS of $0.63, compared to year-ago quarter EPS of $0.74. The stock has a 52-week-high of $40.73 and a 52-week-low of $24.61. At the end of the last trading period, Carlyle Group closed at $27.41. Wedbush upgraded the previous rating for C3.ai Inc (NYSE:AI) from Neutral to Outperform. In the fourth quarter, C3.ai showed an EPS of $0.13, compared to $0.21 from the year-ago quarter. The current stock performance of C3.ai shows a 52-week-high of $44.02 and a 52-week-low of $10.16. Moreover, at the end of the last trading period, the closing price was at $40.01. According to TD Cowen, the prior rating for Phillips 66 (NYSE:PSX) was changed from Market Perform to Outperform. For the first quarter, Phillips 66 had an EPS of $4.21, compared to year-ago quarter EPS of $1.32. The current stock performance of Phillips 66 shows a 52-week-high of $113.53 and a 52-week-low of $74.04. Moreover, at the end of the last trading period, the closing price was at $91.61. GLJ Research upgraded the previous rating for First Solar Inc (NASDAQ:FSLR) from Sell to Hold. For the first quarter, First Solar had an EPS of $0.40, compared to year-ago quarter EPS of $0.41. The current stock performance of First Solar shows a 52-week-high of $232.00 and a 52-week-low of $60.78. Moreover, at the end of the last trading period, the closing price was at $202.96. For Veeva Systems Inc (NYSE:VEEV), Guggenheim upgraded the previous rating of Neutral to Buy. Veeva Sys earned $0.91 in the first quarter, compared to $0.99 in the year-ago quarter. The stock has a 52-week-high of $232.26 and a 52-week-low of $151.06. At the end of the last trading period, Veeva Sys closed at $165.70. For Nucor Corp (NYSE:NUE), Wolfe Research upgraded the previous rating of Underperform to Peer Perform. Nucor earned $4.45 in the first quarter, compared to $7.67 in the year-ago quarter. The stock has a 52-week-high of $182.68 and a 52-week-low of $100.15. At the end of the last trading period, Nucor closed at $132.06. For Kingsoft Cloud Holdings Ltd (NASDAQ:KC), Goldman Sachs upgraded the previous rating of Sell to Neutral. Kingsoft Cloud Hldgs earned $0.25 in the first quarter, compared to $0.29 in the year-ago quarter. The stock has a 52-week-high of $10.13 and a 52-week-low of $1.77. At the end of the last trading period, Kingsoft Cloud Hldgs closed at $4.46. UBS upgraded the previous rating for CSX Corp (NASDAQ:CSX) from Neutral to Buy. CSX earned $0.48 in the first quarter, compared to $0.39 in the year-ago quarter. The stock has a 52-week-high of $34.70 and a 52-week-low of $25.81. At the end of the last trading period, CSX closed at $30.67. For Presto Automation Inc (NASDAQ:PRST), Chardan Capital upgraded the previous rating of Neutral to Buy. In the first quarter, Presto Automation showed an EPS of $0.30, compared to $0.23 from the year-ago quarter. The stock has a 52-week-high of $8.63 and a 52-week-low of $1.23. At the end of the last trading period, Presto Automation closed at $2.72. According to Gordon Haskett, the prior rating for Chewy Inc (NYSE:CHWY) was changed from Hold to Buy. In the first quarter, Chewy showed an EPS of $0.20, compared to $0.04 from the year-ago quarter. The current stock performance of Chewy shows a 52-week-high of $52.88 and a 52-week-low of $22.97. Moreover, at the end of the last trading period, the closing price was at $29.49. For Domino's Pizza Inc (NYSE:DPZ), JP Morgan upgraded the previous rating of Neutral to Overweight. Domino's Pizza earned $2.93 in the first quarter, compared to $2.50 in the year-ago quarter. The stock has a 52-week-high of $425.75 and a 52-week-low of $285.84. At the end of the last trading period, Domino's Pizza closed at $289.85. For Alteryx Inc (NYSE:AYX), B of A Securities upgraded the previous rating of Neutral to Buy. For the first quarter, Alteryx had an EPS of $0.19, compared to year-ago quarter EPS of $0.40. The stock has a 52-week-high of $70.63 and a 52-week-low of $34.70. At the end of the last trading period, Alteryx closed at $38.94. According to UBS, the prior rating for TFI International Inc (NYSE:TFII) was changed from Neutral to Buy. TFI International earned $1.33 in the first quarter, compared to $1.68 in the year-ago quarter. At the moment, the stock has a 52-week-high of $128.93 and a 52-week-low of $71.95. TFI International closed at $105.28 at the end of the last trading period. JP Morgan upgraded the previous rating for Intercorp Financial Services Inc (NYSE:IFS) from Neutral to Overweight. Intercorp Financial Servs earned $0.60 in the first quarter, compared to $3.47 in the year-ago quarter. At the moment, the stock has a 52-week-high of $28.77 and a 52-week-low of $19.89. Intercorp Financial Servs closed at $21.25 at the end of the last trading period. According to Wolfe Research, the prior rating for Equitrans Midstream Corp (NYSE:ETRN) was changed from Peer Perform to Outperform. For the first quarter, Equitrans Midstream had an EPS of $0.22, compared to year-ago quarter EPS of $0.14. At the moment, the stock has a 52-week-high of $9.89 and a 52-week-low of $4.60. Equitrans Midstream closed at $8.53 at the end of the last trading period. For bluebird bio Inc (NASDAQ:BLUE), Barclays upgraded the previous rating of Equal-Weight to Overweight. For the first quarter, bluebird bio had an EPS of $0.21, compared to year-ago quarter EPS of $1.66. The current stock performance of bluebird bio shows a 52-week-high of $8.58 and a 52-week-low of $2.78. Moreover, at the end of the last trading period, the closing price was at $3.35. For Chevron Corp (NYSE:CVX), RBC Capital upgraded the previous rating of Sector Perform to Outperform. Chevron earned $3.55 in the first quarter, compared to $3.36 in the year-ago quarter. At the moment, the stock has a 52-week-high of $189.66 and a 52-week-low of $132.54. Chevron closed at $150.62 at the end of the last trading period. B of A Securities upgraded the previous rating for BRF SA (NYSE:BRFS) from Underperform to Neutral. For the first quarter, BRF had an EPS of $0.18, compared to year-ago quarter EPS of $0.30. At the moment, the stock has a 52-week-high of $3.42 and a 52-week-low of $1.05. BRF closed at $1.64 at the end of the last trading period. See all analyst ratings upgrades. Downgrades Evercore ISI Group downgraded the previous rating for Entergy Corp (NYSE:ETR) from Outperform to Neutral. For the first quarter, Entergy had an EPS of $1.14, compared to year-ago quarter ...Full story available on Benzinga.com

    Benzinga
  • The mean of analysts' price targets for INmune Bio, Inc. (INMB) points to a 98.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

    Zacks Investment Research
  • INMB earnings call for the period ending June 30, 2022.

    The Motley Fool
Page data last updated 07/23/2025 16:16:50 UTC